Works by Kim, Dennis D.

Results: 58
    1

    The 17‐gene stemness score associates with relapse risk and long‐term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia.

    Published in:
    EJHaem, 2022, v. 3, n. 3, p. 873, doi. 10.1002/jha2.466
    By:
    • Kim, Dennis D. H.;
    • Novitzky Basso, Igor;
    • Kim, Taehyung Simon;
    • Yi, Seong Yoon;
    • Kim, Kyoung Ha;
    • Murphy, Tracy;
    • Chan, Steven;
    • Minden, Mark;
    • Pasic, Ivan;
    • Lam, Wilson;
    • Law, Arjun;
    • Michelis, Fotios V.;
    • Gerbitz, Armin;
    • Viswabandya, Auro;
    • Lipton, Jeffrey;
    • Kumar, Rajat;
    • Ng, Stanley W. K.;
    • Stockley, Tracy;
    • Zhang, Tong;
    • King, Ian
    Publication type:
    Article
    2
    3
    4
    5
    6

    Genome-wide genotype-based risk model for survival in acute myeloid leukaemia patients with normal karyotype.

    Published in:
    British Journal of Haematology, 2013, v. 163, n. 1, p. 62, doi. 10.1111/bjh.12492
    By:
    • Choi, Hangseok;
    • Jung, Chulwon;
    • Sohn, Sang Kyun;
    • Kim, Seonwoo;
    • Kim, Hyeoung‐Joon;
    • Kim, Yeo‐Kyeoung;
    • Kim, TaeHyung;
    • Zhang, Zhaolei;
    • Shin, Eun‐Soon;
    • Lee, Jong‐Eun;
    • Moon, Joon Ho;
    • Kim, Sung Hyun;
    • Kim, Kyoung Ha;
    • Mun, Yeung‐Chul;
    • Kim, Hawk;
    • Park, Jinny;
    • Kim, Jhingook;
    • Kim, Dennis (D. H.)
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation.

    Published in:
    Annals of Hematology, 2024, v. 103, n. 4, p. 1187, doi. 10.1007/s00277-024-05639-6
    By:
    • Lucero, Josephine;
    • Alhumaid, Muhned;
    • Novitzky-Basso, Igor;
    • Capo-Chichi, Jose-Mario;
    • Stockley, Tracy;
    • Gupta, Vikas;
    • Bankar, Aniket;
    • Chan, Steven;
    • Schuh, Andre C.;
    • Minden, Mark;
    • Mattsson, Jonas;
    • Kumar, Rajat;
    • Sibai, Hassan;
    • Tierens, Anne;
    • Kim, Dennis D. H.
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35

    Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell Transplantation.

    Published in:
    Cancers, 2025, v. 17, n. 4, p. 651, doi. 10.3390/cancers17040651
    By:
    • Herrity, Elizabeth;
    • Singhabahu, Sanjay;
    • Remberger, Mats;
    • Alfaro Moya, Tommy;
    • Novitzky Basso, Igor;
    • Pasic, Ivan;
    • Lam, Wilson;
    • Law, Arjun D.;
    • Viswabandya, Auro;
    • Gerbitz, Armin;
    • Kumar, Rajat;
    • Kim, Dennis D.;
    • Lipton, Jeffrey H.;
    • Mattsson, Jonas;
    • Michelis, Fotios V.
    Publication type:
    Article
    36

    Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome.

    Published in:
    Acta Haematologica, 2021, v. 144, n. 1, p. 66, doi. 10.1159/000507536
    By:
    • Alanazi, Wael;
    • Chen, Shiyi;
    • Lipton, Jeffrey H.;
    • Kim, Dennis D.;
    • Viswabandya, Auro;
    • Kumar, Rajat;
    • Lam, Wilson;
    • Law, Arjun D.;
    • Al-Shaibani, Zeyad;
    • Mattsson, Jonas;
    • Michelis, Fotios V.
    Publication type:
    Article
    37

    Optimal duration of imatinib treatment/deep molecular response for treatment‐free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 4, p. 779, doi. 10.1111/bjh.17447
    By:
    • Kim, Dennis D. H.;
    • Novitzky‐Basso, Igor;
    • Kim, Taehyung S.;
    • Atenafu, Eshetu G.;
    • Forrest, Donna;
    • Savoie, Lynn;
    • Bence‐Bruckler, Isabelle;
    • Keating, Mary‐Margaret;
    • Busque, Lambert;
    • Delage, Robert;
    • Xenocostas, Anargyros;
    • Liew, Elena;
    • Paulson, Kristjan;
    • Stockley, Tracy;
    • Laneuville, Pierre;
    • Lipton, Jeffrey H.;
    • Kamel‐Reid, Suzanne;
    • Leber, Brian
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Impact of cytomegalovirus (CMV) seroconversion pre‐allogeneic hematopoietic cell transplantation on posttransplant outcomes.

    Published in:
    European Journal of Haematology, 2024, v. 113, n. 4, p. 441, doi. 10.1111/ejh.14251
    By:
    • Sayyed, Ayman;
    • Wilson, Leeann;
    • Stavi, Vered;
    • Chen, Shiyi;
    • Chen, Carol;
    • Mattsson, Jonas;
    • Lipton, Jeffrey H.;
    • Kim, Dennis D.;
    • Viswabandya, Auro;
    • Kumar, Rajat;
    • Lam, Wilson;
    • Law, Arjun D.;
    • Gerbitz, Armin;
    • Pasic, Ivan;
    • Novitzky‐Basso, Igor;
    • Mazzulli, Tony;
    • Michelis, Fotios V.
    Publication type:
    Article
    50